µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© &+0?Xip{Z
=9h!K:,k
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 9;Q|"
T
1¡¢Co-stimulators (or co-stimulating molecules) ]N2!
'c
2¡¢NK-kB &hUEOif
3¡¢Immunoglobulin superfamily $>7T s>8
4¡¢antigen-presenting cell (APC) 34QW^{dgE
5¡¢death domain g[*"LOw
6¡¢CCR and CXCR .D;6
r4S
7¡¢Lectin (or mitogen) GYg
.B<Q.
8¡¢Clusters of differentiation, CD) u* G+=aV.6
9¡¢B7 family W] WH4.y
10¡¢Cytotoxic T lymphocyte, CTL) O^PN{u
11¡¢IL-15 and IL-15 receptor (IL-15R) s(?%A
12¡¢MHC restriction [mQdc?n\
13¡¢Affinity-chromatography a`8]TD
14¡¢Cyctosprin A, CsA FJ^\K+;
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) 4K\o2p?4
N~0ihTG5
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© G[*z,2Kb>
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 d"@ /{O^1
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 8#\|Y~P
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ C_'EO<w$
q(X7e
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© Z\]{{;%4b7
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ =@pD>h/~
ѪҺ²¡Ñ§×¨Òµ£º BY&{fWUo
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿